The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: a neutral viewpoint

Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):577-84. doi: 10.1016/j.numecd.2014.01.004. Epub 2014 Jan 22.

Abstract

Type 2 diabetes mellitus (T2DM) and essential hypertension are often associated, and retrospective data analyses suggest an association between lower blood pressure (BP) values and lower cardiovascular (CV) risk in patients with T2DM. However, the most recent intervention trials fail to demonstrate a further CV risk reduction, for BP levels <130/80 mm Hg, when compared to levels <140/90 mm Hg. Moreover, a J-shaped, rather than a linear, relationship of BP reduction with incident CV events has been strongly suggested. We here debate the main available evidences for and against the concept of 'the lower the better', in the light of the main intervention trials and meta-analyses, with a particular emphasis on the targets to be pursued in elderly patients. Finally, the most recent guidelines of the scientific societies are critically discussed.

Keywords: Anti-hypertensive treatment; Blood pressure target; Elderly; J-shaped curve; Type 2 diabetes.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Biomarkers
  • Blood Pressure / drug effects*
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetic Angiopathies / complications
  • Diabetic Angiopathies / drug therapy
  • Diabetic Cardiomyopathies / complications
  • Diabetic Cardiomyopathies / epidemiology
  • Diabetic Cardiomyopathies / prevention & control
  • Drug Monitoring
  • Evidence-Based Medicine*
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • International Agencies
  • Middle Aged
  • Practice Guidelines as Topic*
  • Precision Medicine
  • Risk Factors
  • Societies, Medical
  • Societies, Scientific
  • Voluntary Health Agencies

Substances

  • Antihypertensive Agents
  • Biomarkers